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CORRESPONDENCE
Re. ‘Doppler Ultrasound Examination of Multiple Sclerosis
Patients and Control Participants: Inter-observer
Agreement and Association with Disease’
We read the article of Laukontaus et al.1 with great interest.
This study, once again, conﬁrms the poor inter-observer
agreement between ultrasound-skilled operators but
without speciﬁc training for CCSVI investigation. It has been
demonstrated already that agreement signiﬁcantly in-
creases when the operators have attended speciﬁc training
and complete their own learning curve.2e4 However, a good
agreement has been reported limitedly to criterion 3 (CSA
<0.3 cm2), ﬁnding it positive in 45% of the control partic-
ipants, in 65% of multiple sclerosis (MS) patients with early
diagnosis (p < .09), and in 70% of MS patients with late
diagnosis (p < .022). These data conﬁrm signiﬁcant differ-
ences between MS patients and healthy control
participants.4
Furthermore, the authors did not investigate the 3b and 2
criteria, recommended in the Consensus approved by seven
Vascular International Scientiﬁc Societies.5 To the contrary,
the authors followed the ESNCH protocol, always negative
when applied for CCSVI, and refused to apply a protocol
speciﬁcally designed to improve reproducibility and com-
parison among studies.4,5
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Re. ‘Doppler Ultrasound Examination of Multiple Sclerosis
Patients and Control Participants: Inter-observer
Agreement and Association with Disease’
We would like to comment on the recently published study
‘Doppler Ultrasound Examination of Multiple Sclerosis Pa-
tients and Control Participants: Inter-observer Agreement
and Association with Disease’ by Laukontaus et al.1
In our opinion this study has some limitations, making
the conclusion questionable. Namely, data are missing on
training of investigators in diagnosis of chronic cerebrospi-
nal venous insufﬁciency (CCSVI).
Diagnosis of extracranial venous system pathologies,
especially in patients with multiple sclerosis (MS), is
demanding, and without speciﬁc training this examination is
very difﬁcult. Likewise, the investigators used different ul-
trasound equipment with different linear probes that could
inﬂuence ﬁnal outcome, bearing in mind standard error in
measurement with contributing human factor.
The authors agreed on CCSVI criterion 3 (CSA  0.3 cm2),
which was seen in 45% of control participants compared
with 65% of MS 2 patients (p ¼ .09) and 70% of the MS
>10 patients (p ¼ .022), and mean CSA measurement,
which was 0.52  0.34 cm2 in control participants against
0.37  0.32 cm2 MS 2 group (p ¼ .007) and
0.36  0.29 cm2 MS >10 group (p ¼ .001). These ﬁndings
indicate that extracranial venous stenosis could be more
common in patients suffering from MS than in healthy
control participants, regardless of disagreement in other
parameters, making presented ultrasound ﬁndings
appropriate.
Besides ultrasound, multidetector CT (MDCT) or catheter
venography and gradient pressure measurement2 should be
done before ﬁnal diagnosis of CCSVI can be made.
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